James Van Der Beek Gives Life Update Amid Cancer Journey: 'I Was So Emotionally Lit Up' first appeared on Parade on Aug 9, ...

Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow after market close. Here’s what to expect. RadNet beat analysts’ revenue expectations by 6.4% last ...

Guardant Health earns the No. 12 rank among its peers in the Medical-Services industry group. GeneDx Holdings WGS, Hims & Hers Health HIMS and Stevanato Group STVN are among the top 5 highly rated ...

New research reveals that updated colorectal cancer screening among younger Americans has led to significant increases in local-stage tumor detection and diagnoses.

James Van Der Beek is sharing the subtle colorectal cancer symptom he ignored before his shocking diagnosis. “There wasn’t ...

Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...

James Van Der Beek has just woken up from a nap as he hops on a Microsoft Teams call.

Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm ...

Raising awareness of medical products and services is a marathon, not a sprint, and Babson Diagnostics has therefore selected a star with plenty of stamina for a long-term partnership. | Raising ...

HealthDay News — Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within 6 months, according to a study ...

Despite the indication of a potential risk, people who receive abnormal results on blood-based colorectal screening tests commonly do not receive the follow-up colonoscopy.

Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up ...